Peripheral Arterial Disease Trial, Recruiting (NCT06238050)

Peripheral Arterial Disease Trial, Recruiting NCT06238050 Sponsor: University Hospital, Angers Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06238050 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be currently admitted as a patient at the hospital running this trial.
You must have a condition called chronic permanent ischemia (poor blood flow to the limbs that has been present for a long time), confirmed by a specific oxygen measurement taken while resting that shows a low reading (below 30mmHg), with or without wounds or tissue damage on the skin.

Who may not be able to join:

You may not be able to join if you currently have severe or unstable heart failure or breathing failure.
You may not be able to join if you have a serious lung condition called COPD at stage 3 or stage 4 (the more advanced stages of the disease).
You may not be able to join if you have an allergy to medical adhesives (sticky materials used in medical patches or dressings).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 241353689

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06238050

Sponsor: University Hospital, Angers

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 241353689

More information: https://clinicaltrials.gov/study/NCT06238050

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be currently admitted as a patient at the hospital running this trial.
You must have a condition called chronic permanent ischemia (poor blood flow to the limbs that has been present for a long time), confirmed by a specific oxygen measurement taken while resting that shows a low reading (below 30mmHg), with or without wounds or tissue damage on the skin.

Who may not be able to join:

You may not be able to join if you currently have severe or unstable heart failure or breathing failure.
You may not be able to join if you have a serious lung condition called COPD at stage 3 or stage 4 (the more advanced stages of the disease).
You may not be able to join if you have an allergy to medical adhesives (sticky materials used in medical patches or dressings).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Angers

Registry

ClinicalTrials.gov

Start date

15 April 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Comparison of clinical characteristics of patients, whether or not they benefit from oxygen therapy in usual practices.; Comparison of biological characteristics of patients, whether or not they benefit from oxygen therapy in usual practices.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov